Abstract:Major depressive disorder (MDD) is a serious mental disorder with unclear pathogenesis. ProBDNF is a precursor protein of brain derived neurotrophic factor (BDNF) expressed in the central nervous system and peripheral tissues. Previous studies showed that blood proBDNF levels in MDD were increased. However, the relationship between proBDNF/p75NTR and inflammatory cytokines in peripheral blood of MDD is unknown. The current study examined the expression of proBDNF and inflammatory markers in patients with major depression. Peripheral blood mononuclear cells (PBMCs) and serum were obtained from depressive patients (n = 32) and normal donors (n = 20). We examined the mRNA and protein expression of proBDNF/p75NTR/sortilin signaling pathway, as well as tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10) in human PBMCs. The Enzyme-Linked Immunosorbent Assay (ELISA) levels of these factors in the sera were also examined. Furthermore, the correlations between each factor and severity of major depression were tested. Of biomarkers studies, we found that proBDNF, p75NTR and sortilin production were significantly increased in PBMCs from MDD patients compared with that from the normal donors. The upregulation of p75NTR in PBMCs was most obvious as determined by qPRC and Western blots. Interestingly, the expression of proBDNF/p75NTR/sortilin signaling pathway in PBMC could be reversed after therapeutic management. Inflammatory cytokines in PBMC from MDD patients were also increased. Consistently, ELISA showed that the levels of p75NTR, sortilin, IL-1β and IL-10 in the serum of major depression were also increased compared with normal donors, and positively correlated with the major depression scores. The levels of IL-1β and IL-10 were also positively correlated with the major depression scores. Intriguingly, the levels of sortilin was positively correlated with IL-1β. Further flow cytometry studies showed that the number of proBDNF and p75NTR positive CD4 + , CD8 + T cells and CD19 + B cells from MDD patients was increased and subsequently reversed after therapeutic management. The findings suggest that the upregulation of proBDNF/p75NTR/sortilin signaling pathway may relate to inflammatory markers in patients with major depression. Our data also suggest that proBDNF/p75NTR/sortilin signaling pathway may serve as biomarkers for MDD.

Correlations Between Probdnf/p75ntr and Inflammatory Markers in Patients with Major Depression

Upregulation of proBDNF/p75NTR signaling in immune cells and its correlation with inflammatory markers in patients with major depression

Linking peripheral IL-6, IL-1 and hypocretin-1 with cognitive impairment from major depression

Association of Anhedonia with Brain-Derived Neurotrophic Factor and Interleukin-10 in Major Depressive Disorder

Increased Plasma Levels of IL-6 Are Associated with Striatal Structural Atrophy in Major Depressive Disorder Patients with Anhedonia

Elevated Plasma Levels of Mature Brain-Derived Neurotrophic Factor in Major Depressive Disorder Patients with Higher Suicidal Ideation

Association between inflammatory cytokines and symptoms of major depressive disorder in adults

Increased expression of ER stress, inflammasome activation, and mitochondrial biogenesis-related genes in peripheral blood mononuclear cells in major depressive disorder

Ndt_a_202329 1695..1700

Fluoxetine Treatment for Major Depression Decreases the Plasma Levels of Cytokines

Tumor Necrosis Factor- Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment

Relaitonship of mean platelet volume to MDD: a retrospecitve study

Resting-state functional connectivity is correlated with peripheral inflammatory markers in patients with major depressive disorder and healthy controls

Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression.

Changes in the Serum Levels of Inflammatory Cytokines in Antidepressant Drug-Naïve Patients with Major Depression

Difference in Proinflammatory Cytokines Produced by Monocytes Between Patients with Major Depressive Disorder and Healthy Controls

Analysis of blood mature BDNF and proBDNF in mood disorders with specific ELISA assays

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment

Major Depression Accompanied with Inflammation and Multiple Cytokines Alterations: Evidences from Clinical Patients to Macaca Fascicularis and LPS-induced Depressive Mice Model.

Mitogen-stimulated cell proliferation and cytokine production in major depressive disorder patients

TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms